Future challenges and opportunities for cancer screening in the COVID-19 era

IF 3.4 3区医学 Q1 HEALTH POLICY & SERVICES

Health Policy and Technology Pub Date : 2023-09-17 DOI:10.1016/j.hlpt.2023.100808

Mojtaba Nouhi , Leon Bijlmakers , Zahra Goudarzi , Samira Alipour , Seyyed Mostafa Hakimzadeh , Pedram Nazari , Reza Jahangiri , Majid Heydari

{"title":"Future challenges and opportunities for cancer screening in the COVID-19 era","authors":"Mojtaba Nouhi , Leon Bijlmakers , Zahra Goudarzi , Samira Alipour , Seyyed Mostafa Hakimzadeh , Pedram Nazari , Reza Jahangiri , Majid Heydari","doi":"10.1016/j.hlpt.2023.100808","DOIUrl":null,"url":null,"abstract":"<div><h3>Objectives</h3><p>The COVID-19 pandemic undermines health service provision and poses threats to health systems in general. This study aims to investigate the early and long-term effects of COVID-19 on cancer screening.</p></div><div><h3>Method</h3><p>We conducted a scoping review, in which we nested the Futures Wheel (FW) method and the Future Polygon (FP) method. PubMed, SCOPUS, and Web of Sciences databases were searched electronically to identify relevant studies published between 1 January 2020 and 25 July 2023. The FW method was applied to identify the early and long-term effects; the FP was applied during a focus group discussion with a group of experts with a view to estimating the lag time between COVID-19 and its effects on cancer screening.</p></div><div><h3>Results</h3><p>A total of 79 studies met the inclusion criteria. We identified 31 early effects and 26 long-term effects of COVID-19, and divided them into four clusters: screening centers, at-risk persons, screening methods, and clinical staff. The first long-term effects of COVID-19 involve a tendency to shift from hospital-based to home-based screening, accompanied by an acceleration in the application of remote screening methods and emerging psychological problems among clinical staff. This may result in an increase in the number of people with serious oncological conditions, more intensive use of advanced therapeutic interventions, higher expenditure and worsening of treatment outcomes.</p></div><div><h3>Conclusion</h3><p>The effects of COVID-19 on cancer screening and its long-term effects on cancer treatment and its outcomes are ominous. A redesign of cancer screening programs may be required so as to make them more flexible and resilient to external shocks.</p></div>","PeriodicalId":48672,"journal":{"name":"Health Policy and Technology","volume":null,"pages":null},"PeriodicalIF":3.4000,"publicationDate":"2023-09-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Health Policy and Technology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2211883723000849","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"HEALTH POLICY & SERVICES","Score":null,"Total":0}

引用次数: 0

Abstract

Objectives

The COVID-19 pandemic undermines health service provision and poses threats to health systems in general. This study aims to investigate the early and long-term effects of COVID-19 on cancer screening.

Method

We conducted a scoping review, in which we nested the Futures Wheel (FW) method and the Future Polygon (FP) method. PubMed, SCOPUS, and Web of Sciences databases were searched electronically to identify relevant studies published between 1 January 2020 and 25 July 2023. The FW method was applied to identify the early and long-term effects; the FP was applied during a focus group discussion with a group of experts with a view to estimating the lag time between COVID-19 and its effects on cancer screening.

Results

A total of 79 studies met the inclusion criteria. We identified 31 early effects and 26 long-term effects of COVID-19, and divided them into four clusters: screening centers, at-risk persons, screening methods, and clinical staff. The first long-term effects of COVID-19 involve a tendency to shift from hospital-based to home-based screening, accompanied by an acceleration in the application of remote screening methods and emerging psychological problems among clinical staff. This may result in an increase in the number of people with serious oncological conditions, more intensive use of advanced therapeutic interventions, higher expenditure and worsening of treatment outcomes.

Conclusion

The effects of COVID-19 on cancer screening and its long-term effects on cancer treatment and its outcomes are ominous. A redesign of cancer screening programs may be required so as to make them more flexible and resilient to external shocks.

查看原文本刊更多论文

COVID-19时代癌症筛查的未来挑战和机遇

COVID-19大流行破坏了卫生服务的提供，并对整个卫生系统构成威胁。本研究旨在探讨COVID-19对癌症筛查的早期和长期影响。我们进行了范围审查，其中我们嵌套了未来轮(FW)方法和未来多边形(FP)方法。以电子方式检索PubMed、SCOPUS和Web of Sciences数据库，以确定2020年1月1日至2023年7月25日之间发表的相关研究。采用FW法鉴定早期和远期效应;在与一组专家进行的焦点小组讨论中应用了该计划，目的是估计COVID-19及其对癌症筛查的影响之间的滞后时间。共有79项研究符合纳入标准。我们确定了31个COVID-19的早期效应和26个长期效应，并将其分为四个集群:筛查中心、高危人群、筛查方法和临床工作人员。COVID-19的第一个长期影响是，人们倾向于从以医院为基础的筛查转向以家庭为基础的筛查，同时远程筛查方法的应用加速，以及临床工作人员中新出现的心理问题。这可能导致患有严重肿瘤疾病的人数增加，更密集地使用先进的治疗干预措施，增加支出和治疗结果恶化。COVID-19对癌症筛查的影响及其对癌症治疗及其结果的长期影响是不祥的。可能需要重新设计癌症筛查项目，使其对外部冲击更具灵活性和弹性。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Health Policy and Technology Medicine-Health Policy

CiteScore

9.20

自引率

3.30%

发文量

审稿时长

88 days

期刊介绍： Health Policy and Technology (HPT), is the official journal of the Fellowship of Postgraduate Medicine (FPM), a cross-disciplinary journal, which focuses on past, present and future health policy and the role of technology in clinical and non-clinical national and international health environments. HPT provides a further excellent way for the FPM to continue to make important national and international contributions to development of policy and practice within medicine and related disciplines. The aim of HPT is to publish relevant, timely and accessible articles and commentaries to support policy-makers, health professionals, health technology providers, patient groups and academia interested in health policy and technology. Topics covered by HPT will include: - Health technology, including drug discovery, diagnostics, medicines, devices, therapeutic delivery and eHealth systems - Cross-national comparisons on health policy using evidence-based approaches - National studies on health policy to determine the outcomes of technology-driven initiatives - Cross-border eHealth including health tourism - The digital divide in mobility, access and affordability of healthcare - Health technology assessment (HTA) methods and tools for evaluating the effectiveness of clinical and non-clinical health technologies - Health and eHealth indicators and benchmarks (measure/metrics) for understanding the adoption and diffusion of health technologies - Health and eHealth models and frameworks to support policy-makers and other stakeholders in decision-making - Stakeholder engagement with health technologies (clinical and patient/citizen buy-in) - Regulation and health economics